Dr. Lisardo Ugidos De La Varga is a highly accomplished oncologist contributing significantly to the field of medical oncology in Madrid, Spain. With extensive experience and a profound commitment to advancing cancer treatment, Dr. Ugidos is currently serving as the Director of Clinical Research at the Vithas Oncology Institute (IOV) in Madrid. His leadership at IOV encompasses three prominent medical centers: Vithas Madrid Arturo Soria University Hospitals, Vithas Madrid La Milagrosa, and Vithas Madrid Aravaca, reinforcing the institute's healthcare strategy focused on specialized institutes. Dr. Ugidos specializes in various aspects of oncology, including lung cancer, head and neck cancer, immunotherapy, molecular targets, oncogeriatrics, and clinical trials. His dedication extends beyond clinical practice, as he also holds the position of President of TOMAKAKU, a multidisciplinary collaborative group on head and neck cancer comprising specialists from the Community of Madrid and Castilla-La Mancha. Dr. Ugidos' remarkable career involves significant contributions to translational research, evidenced by his fellowship in translational oncology at the Methodist Hospital in Houston, USA. Having participated in numerous clinical trials related to immunotherapy and targeted therapies, Dr. Ugidos stands as a key figure in advancing treatment modalities. His comprehensive approach to patient care, including optimizing screening for elderly patients and enhancing their quality of life during antitumor treatments, reflects his commitment to improving cancer care. Born in León in 1977, Dr. Lisardo Ugidos De La Varga graduated in Medicine from the Autonomous University of Madrid in 2001, specializing in Medical Oncology at the Ramón y Cajal Hospital in Madrid between 2002 and 2006. His journey encompasses diverse medical roles, with a focus on delivering exceptional oncological care and pioneering research in the quest for innovative cancer therapies.